and Analysis for the three-month period ended 30 Jun. 2018 To : Director and the President The Stock Exchange of Thailand Summary of the Company’s Financial Position and Operating Result for the 3 and 6

. DOD2019/004 February 20, 2019 Subject: Management’s discussion and analysis of the Company’s operating results for the year 2018 period To: President The Stock Exchange of Thailand DOD Biotech Public

Page 1 of 4 T.K.S. TECHNOLOGIES % GP Y18 Y17 As Reported Total GP 21.3% 23.9% Company 24.1% 23.9% TBSP 16.9% - Company reported %Gross Profit Margin for year 2018 of 21.3%, while showed of 23.9% in

Limited Page 1/14 Management Discussion and Analysis for year 2019 1. Highlights Unit: million Baht Year 2019 Year 2018 P er fo rm a n ce Revenues 12,923 29,910 Sales Volume (k tons) 710 1,447 EBITDA (271

* Note Please find further information in the consolidated financial statements. 1 21 February, 2019 Subject: Management Discussion & Analysis (MD&A) for the year 2018 Attention: The President The

GFPT Public Company Limited Interim Management Discussion and Analysis for the 2nd Quarter 2019 Page 1 of 13 Management Discussion and Analysis This interim MD&A report has been prepared based on the

Performance for Q1’19 Consolidated Income Statement Summary Unit: THB mn Q1'19 Q1'18 % YoY Q4'18 %QoQ Total revenues 6,512 6,340 2.7% 6,519 -0.1% Total revenues from sales 6,366 6,110 4.2% 6,333 0.5% Beverages

Public Company Limited 7 MANAGEMENT DISCUSSION AND ANALYSIS FOR PERIOD ENDED 30 SEPTEMBER 2018 3.3. Cash Flow Analysis Cash and cash equivalents in 3Q 2018 decreased to 33mTHB, down by 31mTHB from the

No. IIG 003/2020 11 November 2020 Subject: Management discussion and analysis for the 9 months ended September 30, 2020 Attn: Governors and President Market for Alternative Investment (MAI) I&I Group

. Liquidity In 2019, the Company had a net decrease of cash and cash equivalents of 375.5 million Baht, divided into cash flow details for each activity as follows: 2018 2019 Cash flow from operating activities